NORTHERN TRUST CORP - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 20 filers reported holding INHIBIKASE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$18,986
+31.5%
28,8720.0%0.00%
Q4 2022$14,436
-44.5%
28,8720.0%0.00%
Q3 2022$26,000
+23.8%
28,8720.0%0.00%
Q2 2022$21,000
-51.2%
28,8720.0%0.00%
Q1 2022$43,000
+2.4%
28,8720.0%0.00%
Q4 2021$42,000
+40.0%
28,872
+83.7%
0.00%
Q3 2021$30,00015,7140.00%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 1,076,500$1,593,0001.68%
Lynwood Capital Management Inc. 120,000$178,0000.19%
Retirement Planning Co of New England, Inc. 116,402$172,0000.10%
Kepos Capital LP 700,000$1,036,0000.08%
HAMILTON LANE ADVISORS LLC 165,635$245,0000.06%
Redmond Asset Management, LLC 122,682$182,0000.05%
SABBY MANAGEMENT, LLC 99,000$147,0000.02%
Antara Capital LP 303,000$448,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$139,0000.01%
Shay Capital LLC 20,000$30,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders